CD274 and neoplasm: Of note, the patient pre-treatment histology showed >5% expression of PD-L1, while post-treatment histology on residual tumor cells revealed attenuation of PD-L1 expression with significant augmentation of PD-L1 expression on immune cellular elements surrounding tumor cells, suggesting the use of combination therapy with an anti-PD-1/PD-L1 agent.